Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Lake Bioscience CoSHSE:600866 -0.60%70 Median PS Value is ¥24.60 as of Jul. 17, 2026, which is 100% below its 10-year median of 0.69. GuruFocus rates SHSE:600866 with a GF Score™ of 70/100 and a GF Value™ of ¥5.86 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 278 Biotechnology companies, Star Lake Bioscience Co ranks better than 87.41% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Star Lake Bioscience Co's Median PS Value or its related term are showing as below:
SHSE:600866'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.12 Med: 0.69 Max: 1.65
Current: 0.2
During the past 13 years, the highest Price to Median PS Value of Star Lake Bioscience Co was 1.65. The lowest was 0.12. And the median was 0.69.
SHSE:600866's Price-to-Median-PS-Value is ranked better than 87.41% of 278
companies
in the Biotechnology industry
Industry Median: 0.635
vs SHSE:600866: 0.20
Star Lake Bioscience Co (SHSE:600866) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Star Lake Bioscience Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
5.01
/
24.60
=
0.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Lake Bioscience Co Median PS Value Related Terms
Star Lake Bioscience Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600866 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.6204.
Star Lake Bioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥9.388.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Lake Bioscience Co (SHSE:600866) has a Median PS Value of ¥24.60 as of Jul. 17, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Star Lake Bioscience Co and its competitors. This is 3465% above median its historical median of 0.69. Over the past decade, Star Lake Bioscience Co's Median PS Value has ranged from 0.12 to 1.65. According to the industry distribution chart, Star Lake Bioscience Co ranks #35 out of 278 companies in the Biotechnology industry, placing it in the top 12.6%.
Is Star Lake Bioscience Co's Median PS Value too high?
Star Lake Bioscience Co's current Median PS Value of ¥24.60 is 3465% above median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 1.65. Based on the distribution chart, Star Lake Bioscience Co ranks #35 out of 278 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #35 out of 278 companies for Median PS Value. This places Star Lake Bioscience Co in the top 13% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.64. Historically, Star Lake Bioscience Co's own Median PS Value has ranged from 0.12 to 1.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.64, based on 278 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Star Lake Bioscience Co and its competitors. For the Biotechnology industry, the median Median PS Value is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Lake Bioscience Co's current Median PS Value is ¥24.60, which is 3465% above median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥5.01 — trading 14.5% below its estimated fair value. The current Median PS Value is ¥24.60, which is 3465% above median its 10-year median of 0.69. Star Lake Bioscience Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current Median PS Value is ¥24.60 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥5.01 is trading 14.5% below its estimated GF Value™ of ¥5.86.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
Median PS Value: ¥24.60 (3465% above median its 10-year median of 0.69)
GF Value™: ¥5.86 vs. price of ¥5.01 (14.5% below fair value)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
70GF Score
Get the complete analysis for SHSE:600866
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
